• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diabetes Res Clin Pract . Impact of comorbidities on mortality in hospitalized influenza patients with diabetes - analysis of the Austrian Health I

tetano

Editor, Senior Moderator
Diabetes Res Clin Pract


. 2021 Mar 17;108758.
doi: 10.1016/j.diabres.2021.108758. Online ahead of print.
Impact of comorbidities on mortality in hospitalized influenza patients with diabetes - analysis of the Austrian Health Insurance


Faisal Aziz[SUP] 1 [/SUP], Felix Aberer[SUP] 1 [/SUP], Othmar Moser[SUP] 2 [/SUP], Caren Sourij[SUP] 3 [/SUP], Dirk von Lewinski[SUP] 3 [/SUP], Susanne Kaser[SUP] 4 [/SUP], Berthold Reichardt[SUP] 5 [/SUP], Harald Sourij[SUP] 6 [/SUP]



Affiliations

Abstract

Aims: To assess the impact of characteristics and comorbidities on the hospitalization rate and 30- and 90-days all-cause mortality after hospitalization for influenza-related illness (IRI) in individuals with diabetes.
Methods: Data of 507,184 individuals with diabetes enrolled in the national Austrian Health Insurance database during 2013-2017 were analyzed. Hospitalization for IRI was defined as per International Classification of Disease 10 codes (J09, J10, J11). All-cause mortality was calculated for 30- and 90-days post-hospitalization.
Results: Of the total diabetes population, 1994 (0.4%) were hospitalized for IRI during 2013-2017. The rate of comorbidities was higher in individiuals who were hospitalized due to IRI as compared with the general diabetes population. Overall 30-days cumulative mortality following hospitalization for IRI was 7.9% and 90-days mortality was 10.3%. The risk (adjusted Hazard Ratio, 95% Confidence Interval) of IRI related 90-days mortality increased with age (50-59: 3.00, 0.65-13.94; 60-69: 4.16, 0.99-17.55; 70-79: 4.79, 1.16-19.76; 80+: 7.15, 1.74-29.46), heart failure (1.97, 1.31-2.98), renal disease (1.50, 1.05-2.14), and Charlson comorbidity index (1.14, 1.08-1.19).
Conclusions: Older age, heart failure, renal disease, and Charlson comorbidity index were significant predictors of mortality following hospitalization for IRI in individuals with diabetes. These findings could help in improving the clinical management and performance of surveillance and health systems concerning IRI in Austria.

Keywords: Comorbidity; Diabetes; Influenza; Mortality.
 
Back
Top Bottom